发明授权
US08309525B2 Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof
有权
治疗2型糖尿病，代谢综合征，心肌损伤和神经变性与人激素及其类似物
- 专利标题： Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof
- 专利标题（中）： 治疗2型糖尿病，代谢综合征，心肌损伤和神经变性与人激素及其类似物
-
申请号： US12451524申请日： 2008-05-28
-
公开(公告)号： US08309525B2公开(公告)日： 2012-11-13
- 发明人: Nir Barzilai , Pinchas Cohen , Radhika Muzumdar
- 申请人： Nir Barzilai , Pinchas Cohen , Radhika Muzumdar
- 申请人地址： US NY Bronx US CA Oakland
- 专利权人： Albert Einstein College of Medicine of Yeshiva University,The Regents of the University of California
- 当前专利权人： Albert Einstein College of Medicine of Yeshiva University,The Regents of the University of California
- 当前专利权人地址： US NY Bronx US CA Oakland
- 代理机构： Amster, Rothstein & Ebenstein LLP
- 国际申请： PCT/US2008/006720 WO 20080528
- 国际公布： WO2008/153788 WO 20081218
- 主分类号： A61K38/16
- IPC分类号： A61K38/16 ; A61K38/17
摘要：
Provided are methods of using humanin and humanin analogs to treat a mammal exhibiting or at risk for insulin resistance, increase insulin sensitivity in a mammal exhibiting or at risk for insulin resistance, treat type-2 diabetes mellitus, metabolic syndrome, and neurodegeneration, treat and prevent myocardial injury, and determine longevity.
公开/授权文献
信息查询
IPC分类:
